Happy Holidays and New Year As my work as a journalist wanes, eclipsed by other writing projects, I’m happy to share my my most recent article, in DoubleBlind magazine, about a topic I am fascinated with. Anyone with thoughts to share, I’m happy to hear! For all its inevitability, death in our society is still … Read More »
Notes From The Cutting Edge: Israeli Researcher Dedi Meiri On Cannabis, Alzheimer’s And Dementia
I recently listened to a webinar where David (Dedi) Meiri spoke about the cannabis research in his lab at the Technion-Israel Institute of Technology. Meiri is best known for his work matching specific components of cannabis to affect different types of cancer. But when the interviewer asked the Israeli researcher which areas of medicine he thought cannabis … Read More »
MAPS Founder Rick Doblin: You’re Never Too Old For A Psychedelic Experience
Rick Doblin founded the Multidisciplinary Association for Psychedelic Studies (MAPS) in 1986, as a “non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.”*. As a non-profit, MAPS is an unlikely player in a drug-development field dominated by big pharma and … Read More »
Guest on the Kannaboom Podcast
It was a great to be able to speak about my work on the Kannaboom podcast – You can hear it here! https://kannaboom.com/47-abbie-rosner-cannabis-journalist
Psychedelic Drugs Can Improve Quality Of Life – And Death – For Older Adults
Even before COVID-19 set off a global tsunami of anxiety and depression, psychedelic drugs were already showing exciting promise for treating these and other intractable mental health conditions. Compass Pathway’s recent raise of $80M to expand research into the clinical uses of psilocybin only affirms that no coronavirus is going to dampen efforts to make … Read More »